A recent survey by the Helping Hand Foundation reveals alarming rates of diabetes, hypertension, and untreated cataracts in ...
Medically reviewed by Kashif J. Piracha, MD Medically reviewed by Kashif J. Piracha, MD Chronic kidney failure, or end-stage ...
VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...
Pulmonary arterial hypertension (PAH) is an increasingly understood disease, with the genetics and pathophysiology mapped out to the extent that new therapies are emerging.1 The epidemiology, however, ...
London, UK, 18 October 2024 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease treatment, today announced that The ...